CRG

CRG is a Houston-based investment firm that provides customized growth capital and structured debt to commercial-stage life sciences, medical devices, and medtech companies. The firm is best understood as a hybrid debt-and-equity provider, not a traditional buyout sponsor, which means it can finance growth without forcing a control change. AI is not a stated focus, though portfolio companies often embed software and data in instruments and devices.

Check sizes are $25M and above, deployed in the United States and selectively internationally. Engagement is at commercial stage, when revenue exists and the financing question is how to fund expansion without excessive equity dilution. Specific portfolio companies in the healthcare AI segment are not provided in the source data.

For healthcare AI founders building life sciences tools, diagnostics, or medtech platforms with commercial revenue, CRG is a useful name when the question is structured growth financing. Pre-revenue software founders should not approach. The right moment is when the company is selling product and weighing dilutive equity against structured capital.